Non-steroidal mineralocorticoid receptor antagonists in non-diabetic kidney disease: a narrative review of mechanisms and clinical advances
{{output}}
Significant advances have been made in elucidating the role of non-steroidal mineralocorticoid receptor antagonists (ns-MRAs) in non-diabetic kidney disease (NDKD). As a key downstream effector of the renin-angiotensin system (RAS), pathological overactivation... ...
